Business Description
Elliptic Laboratories ASA
ISIN : NO0010722283
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.1 | |||||
Equity-to-Asset | 0.89 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | -2.26 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 19.98 | |||||
Beneish M-Score | -2.73 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 24.6 | |||||
3-Year EBITDA Growth Rate | -49.1 | |||||
3-Year EPS without NRI Growth Rate | -43.1 | |||||
3-Year FCF Growth Rate | -40.9 | |||||
3-Year Book Growth Rate | 14.3 | |||||
Future 3-5Y Total Revenue Growth Rate | 96.34 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 30.66 | |||||
9-Day RSI | 39.85 | |||||
14-Day RSI | 45.01 | |||||
6-1 Month Momentum % | -8.03 | |||||
12-1 Month Momentum % | -24.65 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 7.36 | |||||
Quick Ratio | 7.36 | |||||
Cash Ratio | 3.65 | |||||
Days Sales Outstanding | 293.93 | |||||
Days Payable | 17.39 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3 | |||||
Shareholder Yield % | -1.48 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 7.1 | |||||
Operating Margin % | -44.52 | |||||
Net Margin % | -28.63 | |||||
FCF Margin % | -58.88 | |||||
ROE % | -7.92 | |||||
ROA % | -7.1 | |||||
ROIC % | -13.08 | |||||
ROC (Joel Greenblatt) % | -38.44 | |||||
ROCE % | -8.76 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 11.05 | |||||
PS Ratio | 15.67 | |||||
PB Ratio | 3.98 | |||||
Price-to-Tangible-Book | 5 | |||||
EV-to-EBIT | -41.34 | |||||
EV-to-EBITDA | -117.63 | |||||
EV-to-Revenue | 13.67 | |||||
EV-to-FCF | -23.19 | |||||
Price-to-Net-Current-Asset-Value | 8.08 | |||||
Price-to-Net-Cash | 21 | |||||
Earnings Yield (Greenblatt) % | -2.42 | |||||
FCF Yield % | -4.07 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Elliptic Laboratories ASA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 7.604 | ||
EPS (TTM) (€) | -0.021 | ||
Beta | 1.91 | ||
Volatility % | 44.27 | ||
14-Day RSI | 45.01 | ||
14-Day ATR (€) | 0.021471 | ||
20-Day SMA (€) | 1.0839 | ||
12-1 Month Momentum % | -24.65 | ||
52-Week Range (€) | 0.822 - 1.582 | ||
Shares Outstanding (Mil) | 105.27 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Elliptic Laboratories ASA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Elliptic Laboratories ASA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Elliptic Laboratories ASA Frequently Asked Questions
What is Elliptic Laboratories ASA(FRA:EIP)'s stock price today?
When is next earnings date of Elliptic Laboratories ASA(FRA:EIP)?
Does Elliptic Laboratories ASA(FRA:EIP) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |